Coffee Break Life Sciences Start-ups | Overview page

Your safe path through the contract jungle: CDAs, MTAs & Co. | Coffee Break Life Sciences Start-ups #1

30 January 2024

by Dr. Stefanie Greifeneder

Don’t forget: Early stage IP strategy | Coffee Break Life Sciences Start-ups #2

23 February 2024

by Dr. Anja Lunze, LL.M., Tobias Baus, LL.M., Dipl.-Ing.

Tips and tricks for your financing round | Coffee Break Life Sciences Start-ups #3

20 March 2024

by Dr. Niclas von Woedtke, MBA (Kellogg/ WHU)

R&D Collaborations | Coffee Break Life Sciences Start-ups #4

18 April 2024

by Dr. Stefanie Greifeneder

Employment Law in a Nutshell | Coffee Break Life Sciences Start-ups #5

15 May 2024

by Dr. Jan W. Grawe

Consulting Agreements: Dos and Don’ts | Coffee Break Life Sciences Start-ups #6

26 June 2024

by Dr. Angela Knierim

Clinical trials in the pharmaceutical area: tips and tricks for CTA negotiations | Coffee Break Life Sciences Start-ups #7

18 July 2024

Clinical trials in the medical devices area: tips and tricks for CTA negotiations | Coffee Break Life Sciences Start-ups #8

22 August 2024

by Sarah Aschenbrenner

Data Protection for Life Sciences start-ups, particularly in connection with clinical trials | Coffee Break Life Sciences Start-ups #9

27 September 2024

by Dr. Tim Jonathan Schwarz, Phillip Heske

Think big – possible exit strategies | Coffee Break Life Sciences Start-ups #10

20 October 2024

by Alisa Mathes-Salathe

Website, Social Media, Advertising & Co. | Coffee Break Life Sciences Start-ups #11

19 November 2024

by Dr. Angela Knierim

Regulatory Peculiarities |Coffee Break Life Sciences Start Ups #12

20 December 2024

by Dr. Manja Epping, Christoph Behm